Articles On Adherium (ASX:ADR)

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

The ASX had a solid start to the week, gaining over 1 per cent and hitting a record high. The ASX 200 closed 1.3 per cent up at 7,172.8 which is a record closing high although not quite an all-time intra day high. The #ASX 200 rose by 92pt...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

As the quarterlies continue to roll in across the afternoon, here are five prominent companies whose reports you may have missed.   Osteopore (ASX:OSX) The medical scaffold maker made revenues of $318,103 — a company record — and booked gro...

Summary NTL price of New Talisman Gold Mines hit a two-month high today, trading 33.3% higher at AU$0.004. VIP Gloves’ share price shot up by 42% to AU$0.071 in today’s session, posting a new YTD high of AU$0.078. Japara Healthcare’s...

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Leading healthcare investment firm BioScience Managers argues digital therapeutics will be the next big thing in healthcare – but Australia’s at risk of missing out. Hearing the words “digital therapeutics” (or DTx) might make you think of...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week “Another s...

Australian company Adherium (ASX:ADR), which is focused on respiratory eHealth, remote monitoring and data management solutions, has secured subscription commitments totalling $18 million.

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

The ASX finished in the red today dragged down by resources and energy. Materials and Energy stocks lost over 1 per cent each while Tech was the best sector gaining 0.70 per cent. Large caps fared worse than small caps with the ASX 200 losi...

The ASX had a positive day today gaining 0.8 per cent and all sectors finished in the green except resources and energy. Resources and Energy stocks fell 0.24 per cent and 0.55 per cent but the broader ASX 200 rose 0.87 per cent and all oth...

Source:New Africa ,Shutterstock Summary COVID-19 had a significant impact on the HeraMED’s and Adherium’s first half 2021 results. However, the two players made critical developments during the period. HeraMED plans to expand further...

The company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications and its Hailie® solution is designed to help patients achieve better adherence and provide visibility to parents and care...

A quick wrap of the ASX’s key winners and losers on Monday, August 31. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 838 stocks rose, 662 declined and 5...

The sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have hit the relevant ASX small caps this morning. After 100 days of being virus-free, four COVID-19 cases were detected in the country. New Zeal...

Australian company Adherium (ASX: ADR) has announced the appointment of Geoff Feakes as its chief technology officer (CTO).

Telehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both listed and non-listed plays such as healthcare booking service HealthEngine saw demand rise exponentially as the pandemic broke out and this has...

A quick wrap of the ASX’s key winners and losers on Monday, July 13. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 715 stocks rose, 639 decl...

COVID-19 has forced many companies to adjust the way they operate and many companies think it will be lasting. National Australia Bank (NAB) conducted a survey asking businesses to rate the extent they believe changes in their organisation...

A quick wrap of the key winners and losers on Thursday, April 30. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS CODE COMPANY PR...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 61 were in positive territory over the last fortnight, 10 were flat and 66 saw their share prices fall. Code Name...

The announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders begin to pile up and the pre-open share price begins to surge. But while a nod from Australia’s drug and device regulator, the Therapeutic Go...

John Athanasiou, Red Leaf Securities BUY RECOMMENDATIONS Adherium (ADR)   Chart: Share price over the year ADR is a digital health solutions provider. It develops, makes and supplies a broad range of connected medical devices for respirator...

Global funding for telehealth companies surged in the March quarter as investors jumped on what will clearly be a trend for 2020. A total of $US788m ($1.3bn) was invested into this sector making it the top funded digital health segment in t...

New Zealand-based Adherium (ASX: ADR) is set to form a collaborative alliance with US-based HGE Health to remotely evaluate, treat and manage patients with severe asthma and chronic obstructive pulmonary disease. The respiratory device manu...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

  It’s Tuesday team. Here’s what’s going on in the world.   1.  US politician who invested in an ASX-listed medtech jailed for insider trading Australia’s corporate cop, the Australian Securities and Investments Commission (ASIC) has been a...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 136-odd small cap health stocks, 47 saw their share prices fall, 67 improved and 22 were flat. >> Scroll down for a table showing the performance of s...

The new-look ServTech is pushing its virtual reality technology into dentistry training, being paid $500,000 by a new client for VR dental software. The company changed its name to Vection (ASX:VR1) after buying a European software developm...

Air pollution is a growing problem that in recent days has reached our own backyard. Because of the bushfires in surrounding areas, Sydney’s air has been ranked the ninth worst in the world. It’s not the first time in history it’s happened...

Digital health company Adherium(ASX:ADR) has appointed Dr Peter Stratford as its CEO and Mike Motion at its Chief Commercial Officer.

HeraMED’s (ASX:HMD) foetal ultrasound heart rate monitor has got its long awaited green light to enter the US market and it has doubled in just a few days. The US Food and Drug Administration has approved its 510(k) application meaning it c...

Here’s our fortnightly wrap of the major small cap health stock winners and losers. For the second fortnight in a row, Novita Healthcare (ASX:NHL) is the best-performing ASX small cap healthcare stock, up 72 per cent to 7.8c. Novita was the...

At the close of trading session on 24th October 2019, the benchmark index, i.e. S&P/ ASX 200 closed at 6,693.6 points with a rise of 20.5 points. Designing a portfolio for the purpose of making investment requires a meticulous approach....

On Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers will survive the EV revolution, Barry FitzGerald looks at upcoming juniors, and how South Australian small caps are putting themselves back on...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Australian respiratory medical device company Adherium (ASX:ADR) has announced a new strategic data-based initiative with Summatix.

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Adherium (ASX: ADR) shares have risen 19 per cent this morning following news the asthma monitoring firm had received clearance to sell its devices in the US. The Food and Drug Administration (FDA) granted 510(k) clearance for its Hailie se...